Health Policy COE - Results from #90

Health Policy COE

Search

Understanding Social Vulnerability's Impact on Urologic Cancer Care - Rishi Sekar Details In this conversation, Ruchika Talwar interviews Rishi Sekar, a Urologic Oncology Fellow at the University of Michigan, about his research on the Social Vulnerability Index (SVI) and its relevance to urologic cancers. The SVI measures social disadvantage at the community level by considering factors such as income, education, and geographic location. They discuss the potential of SVI to shed light...
Unveiling Price Disparities: Exploring Inpatient Hematuria Evaluation Costs in Rural For-Profit Hospitals - Ian Berger Details Ruchika Talwar and Ian Berger discuss a Urology Practice publication on inpatient hematuria evaluation costs in rural for-profit hospitals. Berger reveals that rural for-profit hospitals' costs are significantly higher than their non-profit counterparts, with a price increase of up to 80% for intermediate-risk and about 60% for high-risk evaluations. He attributes this disparity to the lack of com...
Adherence to Antibiotic Prophylaxis Guidelines Among Patients Undergoing Radical Cystectomy With Ileal Conduit for Bladder Cancer - Megan Prunty Details Megan Prunty joins Ruchika Talwar to discuss a Journal of Urology publication that explores prophylactic antibiotic use in the setting of radical cystectomy. The study used the Premier Healthcare Database to evaluate the use of antibiotics for radical cystectomy from 2015 to 2020 and focused on the subset of patients that get ileal conduits. The study found that only 28% of patients who get cystec...
Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model - Ruchika Talwar Details Ruchika Talwar joins Sam Chang to discuss a Journal of Urology publication focusing on the Mark Cuban Cost Plus Drug Company (MCCPDC), the awareness of the scope of the availability of prescription drugs, and the possible impact it had on our patients. The MCCPDC is a public benefit corporation focused on the manufacturing and distribution of low-price generic drugs. Dr. Talwar explains the benefi...
Health Inequity in Sexual Health Services Among Chinese Men with Prostate Cancer in the Public Hospital Setting, 2021 PCF-Pfizer Health Equity Challenge Award - Marques Shek Nam Ng Details Marques Shek Nam Ng, a recipient of the 2021 PCF-Pfizer Global Health Equity Challenge Awards, joins Charles Ryan in a discussion on research he and colleagues performed on Health Inequity in Sexual Health Services Among Chinese Men with Prostate Cancer in the Public Hospital Setting. In this research study, Ng et al. identified three determinants of health that are specific to sexual health servi...